Navigation Links
US Script Announces RxDirect VIPPS Accreditation
Date:12/10/2007

FRESNO, Calif., Dec. 10 /PRNewswire/ -- US Script, Inc. today announced that its mail order facility, RxDirect, Inc., received accreditation from the National Association of Boards of Pharmacy (NABP) through its Verified Internet Pharmacy Practice Sites(TM) (VIPPS(R)) program. To be VIPPS-accredited, a pharmacy must comply with the licensing and inspection requirements of the state in which it is located and of each state to which it dispenses medications. In addition, it must meet VIPPS criteria, which address such issues as patients' privacy rights, authentication and security of prescription orders, adherence to a recognized quality assurance policy, and provision of meaningful consultation between patients and pharmacists.

"Successful VIPPS accreditation reinforces to our consumers that RxDirect meets or exceeds the rigorous criteria that were developed by NABP in conjunction with state and federal regulatory agencies, professional associations, and consumer advocacy groups," said Craig Darby, R.Ph., president of RxDirect. "VIPPS accreditation demonstrates to current and potential consumers that RxDirect is a recognized professional mail order pharmacy practice site, and that we go above and beyond to demonstrate our overall commitment to our patients."

Founded in 1994 and based in Texarkana, Texas, RxDirect is a full-service mail order and online pharmacy that provides prescription and over-the-counter medications to members of its contract groups. RxDirect was purchased by US Script in 2004. For more information about RxDirect visit http://www.rxdirect.com.

US Script, Inc. is a nationwide pharmacy benefits manager and subsidiary of CenCorp Health Solutions that has pioneered advances in customizable technology for its clients since its founding in 1999. Today, US Script continues its tradition of innovation in an array of products and services created with its clients and their mem
'/>"/>

SOURCE US Script, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. FDA Updates Prescription Guidelines for Blood Thinner
2. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
3. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
4. Prescription labels geared toward pharmacies, not patients
5. AUDIO from Medialink and Pfizer: Prescription for Safer Drugs Discussed in Washington
6. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
7. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
8. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
9. AUDIO from Medialink and Pfizer: A New Prescription for Safer Drugs
10. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
11. New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...J., Dec. 2 Cantel Medica... to discuss the Company,s results for its first qu...t 11:00 AM ET. Participating in the call will be ...esident; Craig A. Sheldon, Senior Vice President a...orporation. Minntech is a Cantel subsidiary. The f...
(Date:12/2/2008)... Ingenious Med (IM) welcomes new CE...der in inpatient practice,management solutions, w...are,software, revenue management, medical servic... nine-year CEO, Dr. Steven Liu, is confident Willi...opment in all sectors, as he steps into,the role....
(Date:12/2/2008)...moms who took it in first 3 months more likely to ...2 (HealthDay News) -- Infants whose mothers take f... an increased risk for respiratory illness, accord...ed to reduce the risk of birth defects, and many c... The researchers examined data on more than 32,000...
(Date:12/2/2008)... researchers at The University of Nottingham has i...cancer. , The research, published in the journal..., USA and funded by a 72,000 grant from the Britis...essor gene, LIMD1, is responsible for protecting t...y for possible new treatments and early screening ...
Breaking Medicine News(10 mins):Health News:Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its First Quarter Ended October 31, 2008 2Health News:Ingenious Med Hires New CEO to Maintain and Further Expand Company Development 2Health News:Folate in Early Pregnancy May Boost Wheezing in Baby 2Health News:Gene which protects against lung cancer identified 2
...study has found that smoking may hamper alcoholics... nine months period of alcohol abstinence . Abou... who take alcoholism treatment are chronic smokers... may interfere with the neurocognitive recovery of...
.../actress Mandy Moore admits that she doesn't mind ... The 23-year-old insisted that its part of her job...t is not a 'personal thing'. "It's not a personal...hat I have to do for my job: shape up a little bit...
...nual UN report on illegal drugs has said that opiu...rol . The World Drug Report says over 90 percent ...mes from Afghanistan. According to a BBC report,...um poppies increased dramatically in the country, ...
...people with diabetes can lose weight if they use p...tion sizes, a new study has found. The study was...lgary, Alberta, Canada led by Dr Sue D. Pedersen, ...onducted a six-month controlled trial of commercia...
Other Medicine News:Health News:Smoking Hampers Alcoholics' Neurocognitive Recovery During Abstinence 2Health News:Smoking Hampers Alcoholics' Neurocognitive Recovery During Abstinence 3Health News:Using Portion-control Dishes can Help Obese Diabetics Lose Weight 2
(Date:11/25/2008)...nst expanding statin use broadly in wake of AHA-pr...25 JUPITER, a clinical trial sugge...sk of healthy patients with elevated CRP, should n...cording to a national poll directed at health prof...e online poll conducted by medical news site MedPa...
(Date:11/25/2008)... Poniard,Pharmaceutical...pany focused on,innovative oncology therapies, an... alternatives for its preclinical research program...urces on the clinical development of picoplatin,...tial commercialization of,picoplatin in the treat...
(Date:11/25/2008)...ial to Assess Survival of Patients Receiving Litx ... Hepatocellular Carcinoma , , BELLEVUE, Was...y, Inc. (LSO) today announced the completion of en...ht Infusion Therapy(TM) (Litx(TM)) as a treatment ...lso known as hepatoma or primary liver cancer. , ...
(Date:11/24/2008)...ov. 24 Takeda Pharmaceutical Compa... Global Research & Development Center, Inc., U...ommittee of the U.S. Food and Drug Administration ... for the treatment of hyperuricemia in patients wi...val, with one panel member abstaining. The vote fo...
Breaking Medicine Technology:Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3Biophysical Society names 2009 award recipients 4751 1Biophysical Society names 2009 award recipients 4751 2Leaders in Pathology Meet in San Diego 3A Sept 25 28 2008 26107 1Leaders in Pathology Meet in San Diego 3A Sept 25 28 2008 26107 2HRSA Announces 2439 Million in Grants to Expand Improve Health Center Services 26105 1HRSA Announces 2439 Million in Grants to Expand Improve Health Center Services 26105 2Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year 7513 1Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year 7513 2
...pr 10, 2007 - Valeant,Pharmaceuticals Internationa...ase 2 data for retigabine, a first-in-class,neuron...ng,independent, scientific journal. The authors co...onstrated reduction in monthly,seizure rates in th... RESTORE2) are currently underway to further inves...
...es Insulin-Free, WASHINGTON, April 10, 2007 /PRNew...lt stem cell therapy, the Journal of the,American ...in which,14 of 15 Juvenile Diabetes patients demon...adult stem cell treatment. According,to U.S. Rep. ... in,that it,s the first attempt at using stem cell...
Other Medicine Technology:Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology 2Valeant Pharmaceuticals Announces Publication of Retigabine Phase 2,Study Data in Neurology 3Newest Adult Stem Therapy Treats Diabetes 2
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump.
...ARE TVT is a minimally invasive, highly effective ...rinary incontinence. GYNECARE TVT is positioned cl...when needed, TVT provides tension-free support of ... takes approximately 20 to 30 minutes, with minima...
SUR-FIT® AutoLock® Urostomy Pouch with Accuseal® Tap
New Image Urostomy Pouch, Ultra-Clear
Medicine Products: